CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for BNB Plus Corp is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

BNB Plus Corp
50 Health Sciences Drive
Phone: (631) 240-8800p:631 240-8800 STONY BROOK, NY  11790  United States Ticker: APDN APDN
Business Summary
BNB Plus Corp., formerly Applied DNA Sciences, Inc., is a digital asset treasury (DAT) company that has adopted BNB, the native cryptocurrency of the Binance blockchain ecosystem, as its primary reserve asset. Its segments include digital asset treasury, therapeutic deoxyribonucleic acid (DNA) production services, DNA tagging and security products and services. Its digital asset treasury segment is engaged in managing digital assets. Its therapeutic DNA production services segment is engaged in nucleic-acid production solutions for the biopharmaceutical and diagnostics industries, including LineaDNA, LineaRNAP and LineaIVT. Its DNA tagging and security products and services segment is engaged in the manufacture and detection of DNA for industrial supply chains and security services. Its subsidiary LineaRx, Inc., is engaged in commercializing nucleic acid production solutions for the biopharmaceutical and diagnostics markets.
(Source: 6-K)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/20259/30/2025YesYes---

Industries
SIC Code Description
2893 Printing ink
7374 Computer processing and data preparation and processing services
2899 Chemicals and chemical preparations, not elsewhere classified
2835 In vitro and in vivo diagnostic substances
6282 Investment advice
2836 Biological products, except diagnostic substances
2865 Cyclic organic crudes and intermediates, and organic dyes and pigments
2833 Medicinal chemicals and botanical products
8071 Medical laboratories
2891 Adhesives and sealants
7389 Business services, not elsewhere classified
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board JoshuaKruger 34 11/6/2025 11/6/2025
President, Chief Executive Officer ClayShorrock 42 9/29/2025 4/1/2021
Chief Financial Officer Beth M.Jantzen 48 2/15/2015 2/15/2015
6 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Vandalia Research, Inc. 1111 Veterans Memorial Blvd Huntington WV United States

Business Names
Business Name
APDN
APDN (B.V.I.) Inc.
Applied DNA Clinical Labs LLC
10 additional Business Names available in full report.

General Information
Number of Employees: 26 (As of 9/30/2025)
Outstanding Shares: 5,447,469 (As of 2/9/2026)
Shareholders: 408
Stock Exchange: NASD
Federal Tax Id: 592262718
Fax Number: (302) 636-5454


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, March 23, 2026